Ohmine K - Search Results

1

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.

Umino K, Morita K, Ikeda T, Kawaguchi SI, Nagayama T, Ito S, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kimura SI, Kako S, Doki N, Ozawa Y, Mori Y, Eto T, Hiramoto N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Nakasone H, Morishima S, Kanda Y. Umino K, et al. Among authors: ohmine k. Blood. 2023 Sep 14;142(11):1008-1021. doi: 10.1182/blood.2023019799. Blood. 2023. PMID: 37363859

2

Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria.

Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T. Kamiie J, et al. Among authors: ohmine k. Pharm Res. 2008 Jun;25(6):1469-83. doi: 10.1007/s11095-008-9532-4. Pharm Res. 2008. PMID: 18219561

3

Oxidative stress is involved in hydroxyurea-induced erythroid differentiation.

Nagai T, Tarumoto T, Miyoshi T, Ohmine K, Muroi K, Komatsu N, Sassa S, Ozawa K. Nagai T, et al. Among authors: ohmine k. Br J Haematol. 2003 May;121(4):657-61. doi: 10.1046/j.1365-2141.2003.04309.x. Br J Haematol. 2003. PMID: 12752110 Free article.

4

Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma.

Yoshida K, Ueno S, Iwao T, Yamasaki S, Tsuchida A, Ohmine K, Ohki R, Choi YL, Koinuma K, Wada T, Ota J, Yamashita Y, Chayama K, Sato K, Mano H. Yoshida K, et al. Among authors: ohmine k. Cancer Sci. 2003 Mar;94(3):263-70. doi: 10.1111/j.1349-7006.2003.tb01431.x. Cancer Sci. 2003. PMID: 12824920 Free article.

5

Relative importance of apoptosis and cell cycle blockage in the synergistic effect of combined R115777 and imatinib treatment in BCR/ABL-positive cell lines.

Miyoshi T, Nagai T, Ohmine K, Nakamura M, Kano Y, Muroi K, Komatsu N, Ozawa K. Miyoshi T, et al. Among authors: ohmine k. Biochem Pharmacol. 2005 Jun 1;69(11):1585-94. doi: 10.1016/j.bcp.2005.02.021. Epub 2005 Apr 12. Biochem Pharmacol. 2005. PMID: 15896338

6

Tracking of specific integrant clones in dogs treated with foamy virus vectors.

Ohmine K, Li Y, Bauer TR Jr, Hickstein DD, Russell DW. Ohmine K, et al. Hum Gene Ther. 2011 Feb;22(2):217-24. doi: 10.1089/hum.2010.072. Epub 2010 Dec 19. Hum Gene Ther. 2011. PMID: 20738155 Free PMC article.

7

GATA suppresses erythropoietin gene expression through GATA site in mouse erythropoietin gene promoter.

Imagawa S, Suzuki N, Ohmine K, Obara N, Mukai HY, Ozawa K, Yamamoto M, Nagasawa T. Imagawa S, et al. Among authors: ohmine k. Int J Hematol. 2002 May;75(4):376-81. doi: 10.1007/BF02982127. Int J Hematol. 2002. PMID: 12041667

8

[Overview].

Ohmine K. Ohmine K. Rinsho Ketsueki. 2016;57(11):2345. doi: 10.11406/rinketsu.57.2345. Rinsho Ketsueki. 2016. PMID: 27941284 Japanese. No abstract available.

9

Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks.

Uchida Y, Ohtsuki S, Kamiie J, Ohmine K, Iwase R, Terasaki T. Uchida Y, et al. Among authors: ohmine k. Drug Metab Pharmacokinet. 2015 Apr;30(2):205-8. doi: 10.1016/j.dmpk.2014.11.002. Epub 2014 Dec 5. Drug Metab Pharmacokinet. 2015. PMID: 25770030

10

DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytes.

Makishima H, Ishida F, Ito T, Kitano K, Ueno S, Ohmine K, Yamashita Y, Ota J, Ota M, Yamauchi K, Mano H. Makishima H, et al. Among authors: ohmine k. Br J Haematol. 2002 Aug;118(2):462-9. doi: 10.1046/j.1365-2141.2002.03646.x. Br J Haematol. 2002. PMID: 12139733 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page